Nov 16, 2019: USFDA approved Zydus Cadila’s Apremilast tablets for the treatment of psoriatic arthritis and moderate to severe plaque psoriasis. The US health regulator to market generic to market the tablets in the strengths of 10 mg, 20 mg, and 30 mg. https://zyduscadila.com/
Zydus Cadila gets tentative approval from USFDA for Apremilast tablets for the treatment of psoriatic arthritis
